ORA Reorganization Includes New Office With Clinical Trial Role

0
165

The FDA’s Office of Regulatory Affairs officially began its transition to a program-based structure May 15, including a new Office of Bioresearch Monitoring Operations that will work with each of the FDA’s product centers to ensure subject protection in clinical studies.

Comments

comments